Some Old Regulatory Issues Revisited: Use of Chebyshev’s Inequality in Decisions Regarding Bioequivalence, One-Sided Rather Than Two-Side P-Values in Placebo Controlled Trials, The Need for Placebo in Combination Trials
Research output: Contribution to conference › Presentation